Liver resection combined with local ablation: Where are the limits?

Digestive Surgery

Volumn 28, Issue 2, 2011, Pages 127-133

  De Jong, Koert P ^a   Wertenbroek, Marieke W J L A E ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Liver tumor; Neoadjuvant chemotherapy; Partial hepatectomy; Thermoablation

Indexed keywords

CATHETER ABLATION; ELECTROMAGNETIC FIELD; HUMAN; LIVER RESECTION; LIVER TUMOR; MULTIMODALITY CANCER THERAPY; REVIEW;

CATHETER ABLATION; COMBINED MODALITY THERAPY; ELECTROMAGNETIC FIELDS; HEPATECTOMY; HUMANS; LIVER NEOPLASMS;

EID: 79955571262     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000323823     Document Type: Review

References (48)

1. Lounsberry W, Goldschmidt V, Linke CA, Walder HJ, Chrzan D: The early histologic changes following electrocoagulation. J Urol 1961;86:321-329.
2. Geddes LA: Retrospectroscope. d'Arsonval, physician and inventor. IEEE Eng Med Biol Mag 1999;18:118-122.
3. d'Arsonval MA: Action physiologigue des courants alternatifs. CR Soc Biol 1891;283-286.
4. Bhardwaj N, Strickland AD, Ahmad F, Dennison AR, Lloyd DM: Liver ablation techniques: a review. Surg Endosc 2010;24:254-265.
5. Kunkle DA, Uzzo RG: Cryoablation or radiofrequency ablation of the small renal mass: a meta-analysis. Cancer 2008;113:2671-2680.
6. Seifert JK, Springer A, Baier P, Junginger T: Liver resection or cryotherapy for colorectal liver metastases: a prospective case control study. Int J Colorectal Dis 2005;20:507-520. (Pubitemid 41479018)
7. Xu KC, Niu LZ, He WB, Hu YZ, Zuo JS: Percutaneous cryosurgery for the treatment of hepatic colorectal metastases. World J Gastroenterol 2008;14:1430-1436.
8. Cho YK, Kim JK, Kim MY, Rhim H, Han JK: Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies. Hepatology 2009;49:453-459.
9. Fischer K, Gedroyc W, Jolesz FA: Focused ultrasound as a local therapy for liver cancer. Cancer J 2010;16:118-124.
10. Dawood O, Mahadevan A, Goodman KA: Stereotactic body radiation therapy for liver metastases. Eur J Cancer 2009;45:2947-2959.
11. Ahmadzadehfar H, Biersack HJ, Ezziddin S: Radioembolization of liver tumors with yttrium-90 microspheres. Semin Nucl Med 2010;40:105-121.
12. Brace CL: Microwave ablation technology: what every user should know. Curr Probl Diagn Radiol 2009;38:61-67.
13. Wicherts DA, Miller R, de Haas RJ, Bitsakou G, Vibert E, Veilhan LA, Azoulay D, Bismuth H, Castaing D, Adam R: Long-term results of two-stage hepatectomy for irresectable colorectal cancer liver metastases. Ann Surg 2008;248:994-1005.
14. Karoui M, Vigano L, Goyer P, Ferrero A, Luciani A, Aglietta M, Delbaldo C, Cirillo S, Capussotti L, Cherqui D: Combined first-stage hepatectomy and colorectal resection in a two-stage hepatectomy strategy for bilobar synchronous liver metastases. Br J Surg 2010;97:1354-1362.
15. Tsai S, Marques HP, de Jong MC, Mira P, Ribeiro V, Choti MA, Schulick RD, Barroso E, Pawlik TM: Two-stage strategy for patients with extensive bilateral colorectal liver metastases. HPB (Oxford) 2010;12:262-269.
16. De Baere T, Risse O, Kuoch V, Dromain C, Sengel C, Smayra T, Gamal El Din M, Letoublon C, Elias D: Adverse events during radiofrequency treatment of 582 hepatic tumors. AJR Am J Roentgenol 2003;181:695-700. (Pubitemid 37021837)
17. Garrean S, Hering J, Saied A, Helton WS, Espat NJ: Radiofrequency ablation of primary and metastatic liver tumors: a critical review of the literature. Am J Surg 2008;195:508-520. (Pubitemid 351417476)
18. de Jong KP, Lont HE, Bijma AM, van Veen ML, Brouwers MAM, de Vries EGE, Marquet RL, Slooff MJH, Terpstra OT: The effect of partial hepatectomy on tumor growth in rats. In vivo and in vitro studies. Hepatology 1995;22:1263-1272.
19. Auguste P, Fallavollita L, Wang N, Burnier J, Bikfalvi A, Brodt P: The host inflammatory response promotes liver metastasis by increasing tumor cell arrest and extravasation. Am J Pathol 2007;170:1781-1792. (Pubitemid 47339320)
20. van der Bij GJ, Oosterling SJ, Beelen RH, Meijer S, Coffey JC, van Egmond M: The perioperative period is an underutilized window of therapeutic opportunity in patients with colorectal cancer. Ann Surg 2009;249:727-734.
21. de Jong KP, Slooff MJH, de Vries EGE, Brouwers MAM, Terpstra OT: Effect of partial liver resection on tumour growth. J Hepatol 1996;25:109-121. (Pubitemid 26267101)
22. de Jong KP, Alting von Geusau B, Rottier CA, Bijzet J, Limburg PC, de Vries EGE, Fidler V, Slooff MJH: Serum response of hepatocyte growth factor, insulin-like growth factor-I, interleukin-6, and acute phase proteins in patients with colorectal liver metastases treated with partial hepatectomy or cryosurgery. J Hepatol 2001;34:422-427. (Pubitemid 32240822)
23. de Jong KP, Hoedemakers RMJ, Fidler V, Bijzet J, Limburg PC, Peeters PMJG, de Vries EGE, Slooff MJH: Portal and systemic serum growth factor and acute phase response after laparotomy or partial hepatectomy in patients with colorectal liver metastases: a prognostic role for C-reactive protein and hepatocyte growth factor. Scand J Gastroenterol 2004;39:1141-1148. (Pubitemid 39536405)
24. Lau WY, Lai EC: The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review. Ann Surg 2009;249:20-25.
25. Massarweh NN, Park JO, Farjah F, Yeung RS, Symons RG, Vaughan TL, Baldwin LM, Flum DR: Trends in the utilization and impact of radiofrequency ablation for hepatocellular carcinoma. J Am Coll Surg 2010;210:441-448.
26. Reddy SK, Pawlik TM, Zorzi D, Gleisner AL, Ribero D, Assumpcao L, Barbas AS, Abdalla EK, Choti MA, Vauthey JN, Ludwig KA, Mantyh CR, Morse MA, Clary BM: Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis. Ann Surg Oncol 2007;14:3481-3491. (Pubitemid 350160107)
27. Martin RC, Augenstein V, Reuter NP, Scoggins CR, McMasters KM: Simultaneous versus staged resection for synchronous colorectal cancer liver metastases. J Am Coll Surg 2009;208:842-850.
28. Van Dijk TH, Hospers GAP, Beukema JC, Beets GL, Gelderblom AJ, de Jong KP, Rutten HJ, Van de Velde CJH, Wiggers T, Havenga K: Short-course radiation therapy, neoadjuvant bevacizumab, capecitabine and oxaliplatin, and radical resection of primary tumour and metastases in primary stage IV rectal cancer: a phase II multicenter study of the Dutch Colorectal Cancer Group. Ann Oncol 2010;21:I51.
29. Roberts JP, Venook A, Kerlan R, Yao F: Hepatocellular carcinoma: ablate and wait versus rapid transplantation. Liver Transpl 2010;16:925-929.
30. Abulkhir A, Limongelli P, Healey AJ, Damrah O, Tait P, Jackson J, Habib N, Jiao LR: Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg 2008;247:49-57.
31. Pamecha V, Levene A, Grillo F, Woodward N, Dhillon A, Davidson BR: Effect of portal vein embolisation on the growth rate of colorectal liver metastases. Br J Cancer 2009;100:617-622.
32. de Graaf W, van den Esschert JW, van Lienden KP, van Gulik TM: Induction of tumor growth after preoperative portal vein embolization: is it a real problem? Ann Surg Oncol 2009;16:423-430.
33. Mayo SC, de Jong MC, Pulitano C, Clary BM, Reddy SK, Gamblin TC, Celinksi SA, Kooby DA, Staley CA, Stokes JB, Chu CK, Ferrero A, Schulick RD, Choti MA, Mentha G, Strub J, Bauer TW, Adams RB, Aldrighetti L, Capussotti L, Pawlik TM: Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multiinstitutional analysis. Ann Surg Oncol 2010;17:3129-3136.
34. Maithel SK, Fong Y: Hepatic ablation for neuroendocrine tumor metastases. J Surg Oncol 2009;100:635-638.
35. Wertenbroek MW, Links TP, Prins TR, Plukker JT, van der Jagt EJ, de Jong KP: Radiofrequency ablation of hepatic metastases from thyroid carcinoma. Thyroid 2008;18:1105-1110.
36. Kloos RT, Eng C, Evans DB, Francis GL, Gagel RF, Gharib H, Moley JF, Pacini F, Ringel MD, Schlumberger M, Wells SA Jr: Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid 2009;19:565-612.
37. Rubino C, De VF, Dottorini ME, Hall P, Schvartz C, Couette JE, Dondon MG, Abbas MT, Langlois C, Schlumberger M: Second primary malignancies in thyroid cancer patients. Br J Cancer 2003;89:1638-1644. (Pubitemid 37464133)
38. Eisele RM, Zhukowa J, Chopra S, Schmidt SC, Neumann U, Pratschke J, Schumacher G: Results of liver resection in combination with radiofrequency ablation for hepatic malignancies. Eur J Surg Oncol 2010;36:269-274.
39. Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR, Hess K, Curley SA: Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004;239:818-825.
40. Nikfarjam M, Shereef S, Kimchi ET, Gusani NJ, Jiang Y, Avella DM, Mahraj RP, Staveley-O'Carroll KF: Survival outcomes of patients with colorectal liver metastases following hepatic resection or ablation in the era of effective chemotherapy. Ann Surg Oncol 2009;16:1860-1867.
41. Berber E, Tsinberg M, Tellioglu G, Simpfendorfer CH, Siperstein AE: Resection versus laparoscopic radiofrequency thermal ablation of solitary colorectal liver metastasis. J Gastrointest Surg 2008;12:1967-1972.
42. Siperstein AE, Berber E, Ballem N, Parikh RT: Survival after radiofrequency ablation of colorectal liver metastases: 10-year experience. Ann Surg 2007;246:559-565. (Pubitemid 47480598)
43. Mulier S, Ni Y, Jamart J, Ruers T, Marchal G, Michel L: Local recurrence after hepatic radiofrequency coagulation: multivariate metaanalysis and review of contributing factors. Ann Surg 2005;242:158-171. (Pubitemid 41033431)
44. Stigliano R, Marelli L, Yu D, Davies N, Patch D, Burroughs AK: Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC. Cancer Treat Rev 2007;33:437-447.
45. Liu SY, Lee KF, Lai PB: Needle track seeding: a real hazard after percutaneous radiofrequency ablation for colorectal liver metastasis. World J Gastroenterol 2009;15:1653-1655.
46. de Jong KP, Prins TR, Hofker HS: A new interventional technique for percutaneous treatment of drainage-resistant liver abscess. Br J Radiol 2010;83:e195-e197.
47. de Jong KP: Review article: multimodality treatment of liver metastases increases suitability for surgical treatment. Aliment Pharmacol Ther 2007;26:161-169.
48. Wong SL, Mangu PB, Choti MA, Crocenzi TS, Dodd GD III, Dorfman GS, Eng C, Fong Y, Giusti AF, Lu D, Marsland TA, Michelson R, Poston GJ, Schrag D, Seidenfeld J, Benson AB III: American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. J Clin Oncol 2010;28:493-508.